Fate Therapeutics Cash from Investing (TTM) Trends

Fate Therapeutics Inc (FATE)

3.76 -0.11 (-2.84%) USD | NASDAQ | Apr 26, 14:26

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	112.66M
September 30, 2023	120.42M
June 30, 2023	176.00M
March 31, 2023	183.12M
December 31, 2022	166.75M
September 30, 2022	184.92M
June 30, 2022	182.50M
March 31, 2022	140.84M
December 31, 2021	-324.02M
September 30, 2021	-561.33M
June 30, 2021	-693.43M
March 31, 2021	-656.74M
December 31, 2020	-161.08M
September 30, 2020	-105.56M
June 30, 2020	-15.14M
March 31, 2020	-142.43M
December 31, 2019	-157.45M
September 30, 2019	-30.55M
June 30, 2019	-53.56M
March 31, 2019	52.14M
December 31, 2018	-0.463M

Date	Value
September 30, 2018	-3.643M
June 30, 2018	-3.281M
March 31, 2018	-15.66M
December 31, 2017	-10.20M
September 30, 2017	-17.42M
June 30, 2017	-30.60M
March 31, 2017	-26.15M
December 31, 2016	-4.114M
September 30, 2016	-10.27M
June 30, 2016	-11.38M
March 31, 2016	-17.39M
December 31, 2015	-1.498M
September 30, 2015	-1.591M
June 30, 2015	-1.123M
March 31, 2015	-0.936M
December 31, 2014	-0.882M
September 30, 2014	-0.761M
June 30, 2014	-0.591M
March 31, 2014	-0.629M
December 31, 2013	-0.238M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-693.43M

Minimum

Jun 2021

184.92M

Maximum

Sep 2022

-86.00M

Average

-30.55M

Median

Sep 2019

Cash from Investing (TTM) Benchmarks